Smallpox Clinical Trials
Here are the 0 most popular medical studies for smallpox
Frequently Asked Questions
Introduction to smallpox
What are the top hospitals conducting smallpox research?
In the domain of infectious diseases, smallpox has had a notorious history. However, in an effort to combat this deadly virus and develop potential treatments or preventive measures, several top hospitals have embarked on clinical trials. Altasciences located in Overland Park leads the charge with one active smallpox trial, marking their first recorded trial in 2023. Meanwhile, Stanford University's General Clinical Research Center joins the fight with another ongoing trial for smallpox treatment or prevention—one that represents their sole contribution to this critical research since their initial involvement back in 2004. Notably, the University of Kentucky's Kentucky Clinic in Lexington and St. Louis University's Center for Vaccine Development each have one active smallpox trial as well—a testament to these institutions' commitment to finding breakthroughs against this age-old menace. Finally, Vanderbilt University Medical Center's General Clinical Research Center adds its own expertise through a single ongoing smallpox study; they also became part of this vital research field in 2004.
Although only one current trial is underway at each hospital mentioned above—reflecting both the rarity and severity of smallpox—the significance lies not just within numbers but rather collectively pushing forward toward understanding and possibly eradicating this disease once and for all. With these healthcare pioneers dedicatedly pursuing solutions against such formidable adversaries like smallpox, there remains hope that we are slowly edging towards a world free from its grip—a world where innocent lives need not be plagued by its devastating consequences any longer
Which are the best cities for smallpox clinical trials?
When it comes to smallpox clinical trials, several cities across the United States are actively involved in research. Among them, Overland Park in Kansas, Stanford in California, Lexington in Kentucky, St. Louis in Missouri, and Nashville in Tennessee each have one ongoing trial focused on treatments for smallpox. These trials aim to explore various potential therapies and advancements for this infectious disease.
Which are the top treatments for smallpox being explored in clinical trials?
Clinical trials are exploring various potential treatments for smallpox, aiming to combat this infectious disease effectively. One prominent contender is tecovirimat, which has shown promising results in early trials. Another treatment being investigated is brincidofovir, offering a potential solution against smallpox infection. Additionally, researchers are studying cidofovir as a possible therapeutic option for this highly contagious illness. These ongoing clinical trials bring hope for improved management and treatment of smallpox in the future.
What are the most recent clinical trials for smallpox?
Recent clinical trials have been conducted to explore potential treatments for smallpox. One such trial investigated the efficacy of Treatment AB - Form H, a test tablet designed specifically for smallpox. This Phase 1 trial commenced on 5/30/2023 and aims to evaluate the safety and tolerability of this treatment option. Additionally, another study focused on developing effective treatments for smallpox through Phase 1 and Phase 2 trials, with results becoming available as early as 10/1/2004. These ongoing research efforts aim to improve our understanding of smallpox management and offer hope for future therapeutic advancements in combating this infectious disease.
What smallpox clinical trials were recently completed?
Recently completed clinical trials have made significant progress in the field of smallpox research. These trials include a study sponsored by the National Institutes of Health (NIH) that investigated the efficacy of Arestvyr, an antiviral drug, in treating smallpox infections. Another trial focused on Tecovirimat, also known as ST-246, which was developed to combat various orthopoxviruses including smallpox. These advancements signify important breakthroughs in our understanding and treatment options for this highly contagious and potentially deadly disease.